newsfilter
← Latest News
GlobeNewswire·

Celyad Oncology to Announce First Half 2022 Financial Results and Host Conference Call

MONT-SAINT-GUIBERT, Belgium, July 28, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA ((Euronext &, NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for canc